Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.

about

The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers

P2860

Q58702607-420D7143-D817-4EE8-8623-DB22143043E7

P2860

Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.

Item

http://www.wikidata.org/entity/Q38599086

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel quinolone chalcones targ ...... in activity and MRP1 function.

@en

type

Item

label

Novel quinolone chalcones targ ...... in activity and MRP1 function.

@en

prefLabel

Novel quinolone chalcones targ ...... in activity and MRP1 function.

@en

P1476

Novel quinolone chalcones targ ...... in activity and MRP1 function.

@en

P2093

Chandrabose Karthikeyan

http://www.w3.org/2001/XMLSchema#string

Hai-Yen Vu

http://www.w3.org/2001/XMLSchema#string

Hoyun Lee

http://www.w3.org/2001/XMLSchema#string

I Kalhari Lindamulage

http://www.w3.org/2001/XMLSchema#string

James Knockleby

http://www.w3.org/2001/XMLSchema#string

Piyush Trivedi

http://www.w3.org/2001/XMLSchema#string

Yi-Fang Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

Targeting BCL2-Proteins for the Treatment of Solid Tumours

Molecular targeted approaches to cancer therapy and prevention using chalcones

Microtubule-binding agents: a dynamic field of cancer therapeutics.

A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors

S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton

An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics

The landscape of somatic copy-number alteration across human cancers.

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

P2888

s41598-017-10972-0

P304

10298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-10972-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091356787

http://www.w3.org/2001/XMLSchema#string

P698

28860494

http://www.w3.org/2001/XMLSchema#string

P819

2017NatSR...710298L

http://www.w3.org/2001/XMLSchema#string

P921

quinolone

binding pocket

multiple drug resistance

P932

5578999

http://www.w3.org/2001/XMLSchema#string

Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.

about

P2860

P2860

Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P819

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P819

P921

P932